High-Purity p-Nitro-o-Anisidine for Pharmaceutical Intermediates from Canada
High-purity p-nitro-o-anisidine (99.5%) for pharmaceutical synthesis is classified under HTS 2922.29.81.10 as a pure oxygen-function amino-phenol ether. Its nitro and methoxy groups enable reduction to key drug scaffolds.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.6093.5%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Obtain DMF or equivalent for pharma imports; cross-check with FDA chemical database
• Ensure <10 ppm heavy metals per USP standards to avoid Chapter 28 inorganic classification